Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BB Biotech Ventures II is a venture capital fund focused on the life sciences and healthcare sectors, managed by Bellevue Asset Management. As the second dedicated venture fund associated with the Swiss investment company BB Biotech AG, it provides growth capital to private companies developing innovative therapeutics, medical devices, and diagnostics. The fund targets high-growth opportunities in Europe and North America, leveraging a team of scientific and financial experts to identify breakthrough medical technologies. BB Biotech Ventures II has historically invested in a diverse range of therapeutic areas, supporting portfolio companies through clinical development and toward successful exits such as initial public offerings or strategic acquisitions. The fund plays a critical role in the broader BB Biotech ecosystem by fostering early-stage innovation that complements the group's public market investments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BB Biotech Ventures II.